Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

Clinical trial NCT06316427 · RECRUITING

Trial details

NCT number: NCT06316427
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoblastic Leukemia T-cell Malignancies

Start date: 2024-03-22
Primary completion: 2026-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.